Article
A nematode-specific gene underlies bleomycin-response variation in <i>Caenorhabditis elegans</i>
2019-03-01
Abstract excerpt
<h4>ABSTRACT</h4> Bleomycin is a powerful chemotherapeutic drug used to treat a variety of cancers. However, individual patients vary in their responses to bleomycin. The identification of genetic differences that underlie this response variation could improve treatment outcomes by tailoring bleomycin dosages to each patient. We used the model organism Caenorhabditis elegans to identify genetic determinants of b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 636a9df4-a010-5230-bf10-da5b8509bdd8
- DOI
- 10.1101/565218
